Respiratory disease
Conditions
Interventions
None listed
Sponsors
Tokyo Medical University, Hachioji Medical Center Respiratory Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients whose PaCO2 is to be monitored and who agree to measure their EtCO2 simultaneously. 2. Patients who can understand the clinical study and who agree to participate in the study with the written informed consent. 3. Patients aged between 20 years and 85 years old. Or patients aged 16 years or over and less than 20 years at the time of Informed Consent with consent by legal representatives. 4. Inpatients or outpatients with respiratory / ventilatory dysfunction that range from mild to severe, who are able to follow the investigator's instructions.
Exclusion criteria
Exclusion criteria: 1. Patients who are unable to take continuous mouth-breaths at least 8 cycles. 2. Patients who are unable to understand investigator's instructions, e.g. dementia and psychiatric disease. 3. Patients who undergo with Photo Dynamic Therapy and/or defibrillator as combination therapy. 4. Any other cases who are considered as inappropriate for the study by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the performance of CapnoEye by calculating correlation coefficient between PaCO2 measured with arterial blood gas and EtCO2 measured by CapnoEye. | — |
Secondary
| Measure | Time frame |
|---|---|
| - The explorative sub-group analysis for tendency (high vs low PaCO2, obstructive/restrictive/mixed disease, relationship with respiration rate) - Safety data (medical device malfunction, adverse events). | — |
Countries
Japan
Contacts
Public ContactToshio Ichiwata
Tokyo Medical University, Hachioji Medical Center Respiratory Medicine
Outcome results
None listed